Reportable Segment — Equity Method Investments
Business Segments · Equity Method InvestmentsEli Lilly Reportable Segment — Equity Method Investments decreased by 15.1% to $33.80M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 88.2%, from $285.68M to $33.80M.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ3 2025
How to read this metric
An increase indicates ongoing investment in strategic partnerships, while a decrease may signal divestment or impairment.
Detailed definition
Represents the carrying value of investments in entities where the segment holds significant influence but not control....
Peer comparison
Commonly reported by large pharmaceutical firms engaged in collaborative drug development.
Metric ID:
lly_segment_reportable_segment_equity_method_investmentsHistorical Data
11 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $240.58M | $240.58M | $240.58M | $240.58M | $285.68M | $285.68M | $285.68M | $285.68M | $1.15B | $39.80M | $33.80M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +18.7% | +0.0% | +0.0% | +0.0% | +302.1% | -96.5% | -15.1% |
| YoY Change | — | — | — | — | +18.7% | +18.7% | +18.7% | +18.7% | +302.1% | -86.1% | -88.2% |
Range$33.80M – $1.15B
CAGR-54.4%
Avg YoY Growth+29.0%
Median YoY Growth+18.7%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's reportable segment — equity method investments?
- Eli Lilly (LLY) reported reportable segment — equity method investments of $33.80M in Q3 2025.
- How has Eli Lilly's reportable segment — equity method investments changed year-over-year?
- Eli Lilly's reportable segment — equity method investments decreased by 88.2% year-over-year, from $285.68M to $33.80M.
- What does reportable segment — equity method investments mean?
- The book value of the segment's ownership stakes in other companies.